Medical Surgical Nursing | Common Neurological Disorders and Nursing Management | Parkinson's Disease |
Parkinson's Disease :
Definition
Parkinson's Disease (PD) is a chronic, progressive neurological disorder primarily affecting movement due to the degeneration of dopamine-producing neurons in the substantia nigra, a region of the brain. It is characterized by motor symptoms such as tremors, rigidity, bradykinesia, and postural instability, along with non-motor symptoms.
Causes
The exact cause of Parkinson's Disease is unknown, but it is believed to result from a combination of genetic, environmental, and lifestyle factors. Key causes include:
Genetic Mutations: Mutations in genes such as LRRK2, PARK7, and SNCA.
Environmental Triggers: Exposure to pesticides, herbicides, and industrial toxins.
Oxidative Stress: Damage to neurons due to free radicals.
Aging: Increased vulnerability to neuronal degeneration with age.
Types
Idiopathic Parkinson's Disease: Most common type with no identifiable cause.
Secondary Parkinsonism: Caused by medications (antipsychotics), toxins, or brain injuries.
Atypical Parkinsonism: Associated with other neurodegenerative conditions such as Multiple System Atrophy (MSA) or Progressive Supranuclear Palsy (PSP).
Signs and Symptoms
Motor Symptoms:
Tremors: Resting tremors, often beginning in one limb.
Rigidity: Muscle stiffness, leading to resistance during movement.
Bradykinesia: Slowness of movement, difficulty initiating actions.
Postural Instability: Impaired balance, leading to falls.
Non-Motor Symptoms:
Cognitive decline and memory problems.
Depression, anxiety, and apathy.
Sleep disturbances (REM behavior disorder).
Autonomic dysfunction: Constipation, urinary retention, and hypotension.
Pathophysiology
Dopaminergic Neuron Loss: Degeneration of neurons in the substantia nigra reduces dopamine levels in the basal ganglia.
Lewy Bodies: Abnormal protein aggregates (alpha-synuclein) in neurons impair cellular function.
Disrupted Neural Communication: Dopamine deficiency disrupts motor control and coordination.
Progression: As the disease advances, other neurotransmitters (like serotonin and norepinephrine) are also affected, worsening symptoms.
Investigations
Clinical Diagnosis: Based on symptoms and history.
Imaging Studies:
MRI: Rules out structural brain abnormalities.
DaTSCAN: Assesses dopamine transporter activity.
Laboratory Tests: Rule out other conditions (e.g., thyroid dysfunction).
Neuropsychological Testing: Evaluates cognitive and emotional health.
Medications
Dopaminergic Agents:
Levodopa-Carbidopa: Converts to dopamine in the brain.
Dopamine Agonists: Pramipexole, Ropinirole.
MAO-B Inhibitors: Selegiline, Rasagiline (inhibit dopamine breakdown).
COMT Inhibitors: Entacapone (extend the effect of Levodopa).
Anticholinergics: Trihexyphenidyl (reduce tremors).
Amantadine: Improves dyskinesia and motor symptoms.
Nursing Management
Assessment:
Monitor motor and non-motor symptoms.
Assess risk of falls and injury.
Observe for side effects of medications.
Interventions:
Mobility:
Encourage regular physical therapy and exercises.
Use assistive devices for walking and transfers.
Nutrition:
Provide a high-fiber diet to manage constipation.
Small, frequent meals to prevent fatigue.
Medication Management:
Administer medications on time to maintain therapeutic levels.
Educate about side effects and adherence.
Psychological Support:
Provide counseling to manage depression and anxiety.
Encourage participation in support groups.
Prevent Complications:
Turn the patient frequently to prevent pressure ulcers.
Monitor for aspiration during meals.
Rehabilitation
Physical Therapy: Enhances motor function and reduces stiffness.
Occupational Therapy: Aids in daily living activities and use of adaptive devices.
Speech Therapy: Improves speech clarity and addresses swallowing difficulties.
Social Support: Connect patients with community resources and support groups.

Comments
Post a Comment